Oral LD50 is 185 mg/kg in rats.L42780
Due to its actions on opioid receptors, loperamide has been misused and abused to self-manage opioid withdrawal symptoms and to induce euphoria.A251610, A251625 However, loperamide is associated with a risk of experiencing a range of adverse effects, often life-threatening, if taken for non-therapeutic reasons or at doses higher than the recommended dose.L42790 Loperamide overdose can lead to a range of cardiac and non-cardiac effects. Chronic ingestion of doses ranging from 70 mg to 1600 mg daily - which is four to 100 times the recommended dose - resulted in life-threatening cardiac adverse reactions, including QT/QTc and QRS interval prolongation, Torsades de Pointes, Brugada syndrome and other ventricular arrhythmias, syncope, cardiac arrest, and death. These cases included instances of loperamide misuse and abuse. In case of cardiac effects, it is recommended that loperamide is discontinued and therapies to manage and prevent cardiac arrhythmias are initiated.L42790 Cases of loperamide overdose may cause opioid toxic effects including CNS depression (e.g. altered mental status, stupor, coordination disorders, somnolence, miosis, muscular hypertonia, respiratory depression), hypotension, urinary retention, and paralytic ileus.L42790 Naloxone may reverse the opioid-related toxicity, including CNS and respiratory depression, and hypotension, associated with loperamide overdosage.L42790
Loperamide is an anti-diarrheal agent that is available as an over-the-counter product for treating diarrhea.L42785 The drug was first synthesized in 1969 and used medically in 1976.A251610 It is a highly lipophilic synthetic phenylpiperidine opioid that works by binding to mu-opioid receptors on intestinal muscles to decrease intestinal motility and electrolyte loss.A251610 Loperamide has a chemical structure that is similar to diphenoxylate and haloperidol;A6249 however, loperamide works on mu (?)-opioid receptors to mediate its pharmacological actions.A251610
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Loperamide may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Loperamide may increase the bradycardic activities of Ivabradine. |
| Eliglustat | The serum concentration of Loperamide can be increased when it is combined with Eliglustat. |
| Cilostazol | The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Loperamide. |
| Colchicine | The serum concentration of Colchicine can be increased when it is combined with Loperamide. |
| Fentanyl | Fentanyl may increase the bradycardic activities of Loperamide. |
| Iloperidone | The risk or severity of QTc prolongation can be increased when Loperamide is combined with Iloperidone. |
| Tofacitinib | Loperamide may increase the bradycardic activities of Tofacitinib. |
| Vardenafil | The excretion of Loperamide can be decreased when combined with Vardenafil. |
| Cimetidine | The metabolism of Loperamide can be decreased when combined with Cimetidine. |
| Clopidogrel | The metabolism of Loperamide can be decreased when combined with Clopidogrel. |
| Efavirenz | The metabolism of Loperamide can be decreased when combined with Efavirenz. |
| Dantrolene | The risk or severity of hyperkalemia can be increased when Loperamide is combined with Dantrolene. |
| Mifepristone | The serum concentration of Loperamide can be increased when it is combined with Mifepristone. |
| Tacrolimus | The excretion of Loperamide can be decreased when combined with Tacrolimus. |
| Atorvastatin | The metabolism of Atorvastatin can be decreased when combined with Loperamide. |
| Mirabegron | The excretion of Loperamide can be decreased when combined with Mirabegron. |
| Boceprevir | The metabolism of Loperamide can be decreased when combined with Boceprevir. |
| Carteolol | Loperamide may increase the arrhythmogenic activities of Carteolol. |
| Tocainide | Loperamide may increase the arrhythmogenic activities of Tocainide. |
| Metipranolol | Loperamide may increase the arrhythmogenic activities of Metipranolol. |
| Xylometazoline | Loperamide may increase the arrhythmogenic activities of Xylometazoline. |
| Fasudil | Loperamide may increase the arrhythmogenic activities of Fasudil. |
| Tropisetron | Loperamide may increase the arrhythmogenic activities of Tropisetron. |
| Spiradoline | Loperamide may increase the arrhythmogenic activities of Spiradoline. |
| Tiracizine | Loperamide may increase the arrhythmogenic activities of Tiracizine. |
| Ethacizine | Loperamide may increase the arrhythmogenic activities of Ethacizine. |
| Hydroquinine | Loperamide may increase the arrhythmogenic activities of Hydroquinine. |
| Bioallethrin | Loperamide may increase the arrhythmogenic activities of Bioallethrin. |
| Fosfructose | Loperamide may increase the arrhythmogenic activities of Fosfructose. |
| Hydroquinidine | Loperamide may increase the arrhythmogenic activities of Hydroquinidine. |
| SOR-C13 | Loperamide may increase the arrhythmogenic activities of SOR-C13. |
| Acetyldigitoxin | Acetyldigitoxin may increase the arrhythmogenic activities of Loperamide. |
| Deslanoside | Loperamide may increase the arrhythmogenic activities of Deslanoside. |
| Cymarin | Loperamide may increase the arrhythmogenic activities of Cymarin. |
| Ibutilide | Ibutilide may increase the arrhythmogenic activities of Loperamide. |
| Atropine | Atropine may increase the arrhythmogenic activities of Loperamide. |
| Adenosine | Adenosine may increase the arrhythmogenic activities of Loperamide. |
| Levosimendan | Loperamide may increase the arrhythmogenic activities of Levosimendan. |
| Tedisamil | Loperamide may increase the arrhythmogenic activities of Tedisamil. |
| Melperone | Loperamide may increase the arrhythmogenic activities of Melperone. |
| Simendan | Loperamide may increase the arrhythmogenic activities of Simendan. |
| Nizofenone | Loperamide may increase the arrhythmogenic activities of Nizofenone. |
| Bunaftine | Loperamide may increase the arrhythmogenic activities of Bunaftine. |
| Lorcainide | Loperamide may increase the arrhythmogenic activities of Lorcainide. |
| Hyoscyamine | Hyoscyamine may increase the arrhythmogenic activities of Loperamide. |
| Moricizine | Moricizine may increase the arrhythmogenic activities of Loperamide. |
| Bretylium | Loperamide may increase the arrhythmogenic activities of Bretylium. |
| Encainide | Loperamide may increase the arrhythmogenic activities of Encainide. |
| Ajmaline | Loperamide may increase the arrhythmogenic activities of Ajmaline. |
| Methsuximide | Loperamide may increase the arrhythmogenic activities of Methsuximide. |
| Vernakalant | Loperamide may increase the arrhythmogenic activities of Vernakalant. |
| Cariporide | Loperamide may increase the arrhythmogenic activities of Cariporide. |
| Pilsicainide | Loperamide may increase the arrhythmogenic activities of Pilsicainide. |
| Cicletanine | Loperamide may increase the arrhythmogenic activities of Cicletanine. |
| Cibenzoline | Loperamide may increase the arrhythmogenic activities of Cibenzoline. |
| Prajmaline | Loperamide may increase the arrhythmogenic activities of Prajmaline. |
| Lorajmine | Loperamide may increase the arrhythmogenic activities of Lorajmine. |
| Lamotrigine | Lamotrigine may increase the arrhythmogenic activities of Loperamide. |
| Nicorandil | Loperamide may increase the arrhythmogenic activities of Nicorandil. |
| Fosinoprilat | Loperamide may increase the arrhythmogenic activities of Fosinoprilat. |
| Digoxin | Digoxin may increase the arrhythmogenic activities of Loperamide. |
| Metildigoxin | Loperamide may increase the arrhythmogenic activities of Metildigoxin. |
| Acetyldigoxin | Loperamide may increase the arrhythmogenic activities of Acetyldigoxin. |
| Sparteine | Loperamide may increase the arrhythmogenic activities of Sparteine. |
| Aprindine | Loperamide may increase the arrhythmogenic activities of Aprindine. |
| Procainamide | Loperamide may increase the arrhythmogenic activities of Procainamide. |
| Flecainide | Loperamide may increase the arrhythmogenic activities of Flecainide. |
| Ziconotide | Loperamide may increase the arrhythmogenic activities of Ziconotide. |
| Landiolol | Loperamide may increase the arrhythmogenic activities of Landiolol. |
| Atenolol | Atenolol may increase the arrhythmogenic activities of Loperamide. |
| Alprenolol | Loperamide may increase the arrhythmogenic activities of Alprenolol. |
| Pindolol | Loperamide may increase the bradycardic activities of Pindolol. |
| Practolol | Loperamide may increase the arrhythmogenic activities of Practolol. |
| Penbutolol | Loperamide may increase the bradycardic activities of Penbutolol. |
| Dexpropranolol | Loperamide may increase the arrhythmogenic activities of Dexpropranolol. |
| Bufuralol | Loperamide may increase the bradycardic activities of Bufuralol. |
| Bopindolol | Loperamide may increase the bradycardic activities of Bopindolol. |
| Levobetaxolol | Loperamide may increase the bradycardic activities of Levobetaxolol. |
| Esatenolol | Loperamide may increase the bradycardic activities of Esatenolol. |
| Cloranolol | Loperamide may increase the bradycardic activities of Cloranolol. |
| Mepindolol | Loperamide may increase the bradycardic activities of Mepindolol. |
| Epanolol | Loperamide may increase the bradycardic activities of Epanolol. |
| Tertatolol | Loperamide may increase the arrhythmogenic activities of Tertatolol. |
| Labetalol | Labetalol may increase the bradycardic activities of Loperamide. |
| Bevantolol | Loperamide may increase the bradycardic activities of Bevantolol. |
| Bucindolol | Loperamide may increase the bradycardic activities of Bucindolol. |
| Betaxolol | Betaxolol may increase the arrhythmogenic activities of Loperamide. |
| Acebutolol | Loperamide may increase the arrhythmogenic activities of Acebutolol. |
| Oxprenolol | Loperamide may increase the arrhythmogenic activities of Oxprenolol. |
| Indenolol | Loperamide may increase the arrhythmogenic activities of Indenolol. |
| Esmolol | Esmolol may increase the arrhythmogenic activities of Loperamide. |
| Celiprolol | Loperamide may increase the arrhythmogenic activities of Celiprolol. |
| Bupranolol | Loperamide may increase the arrhythmogenic activities of Bupranolol. |
| Talinolol | Loperamide may increase the arrhythmogenic activities of Talinolol. |
| Anisodamine | Loperamide may increase the arrhythmogenic activities of Anisodamine. |
| Nadolol | Loperamide may increase the arrhythmogenic activities of Nadolol. |
| Sotalol | Sotalol may increase the arrhythmogenic activities of Loperamide. |
| Magnesium sulfate | Magnesium sulfate may increase the arrhythmogenic activities of Loperamide. |
| Magnesium salicylate | The risk or severity of hyperkalemia can be increased when Loperamide is combined with Magnesium salicylate. |